WHO expects hydroxychloroquine safety findings by mid-June

Administrator_India | May 27, 2020 | 0 | Coronavirus News

By Administrator_India

Capital Sands

The World Health Organization  on Tuesday promised a swift review of data on hydroxychloroquine, probably by mid-June, after safety concerns prompted the group to suspend the malaria drug’s use in a large trial on COVID-19 patients.

U.S. President Donald Trump and others have pushed hydroxychloroquine as a coronavirus treatment, but the WHO on Monday called time after the British journal The Lancet reported patients getting hydroxychloroquine had increased death rates and irregular heartbeats.

“A final decision on the harm, benefit or lack of benefit of hydroxychloroquine will be made once the evidence has been reviewed,” the body said. “It is expected by mid-June.”

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *